nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiagabine—CYP3A4—breast cancer	0.273	1	CbGaD
Tiagabine—CYP3A4—Exemestane—breast cancer	0.0547	0.133	CbGbCtD
Tiagabine—CYP3A4—Letrozole—breast cancer	0.0465	0.113	CbGbCtD
Tiagabine—CYP3A4—Anastrozole—breast cancer	0.0414	0.101	CbGbCtD
Tiagabine—CYP3A4—Toremifene—breast cancer	0.0379	0.0921	CbGbCtD
Tiagabine—CYP3A4—Fulvestrant—breast cancer	0.0352	0.0856	CbGbCtD
Tiagabine—CYP3A4—Thiotepa—breast cancer	0.0314	0.0763	CbGbCtD
Tiagabine—CYP3A4—Ixabepilone—breast cancer	0.0287	0.0698	CbGbCtD
Tiagabine—CYP3A4—Lapatinib—breast cancer	0.0276	0.0672	CbGbCtD
Tiagabine—CYP3A4—Raloxifene—breast cancer	0.0209	0.0509	CbGbCtD
Tiagabine—CYP3A4—Vinorelbine—breast cancer	0.0153	0.0373	CbGbCtD
Tiagabine—CYP3A4—Tamoxifen—breast cancer	0.0138	0.0336	CbGbCtD
Tiagabine—CYP3A4—Mitoxantrone—breast cancer	0.0135	0.0328	CbGbCtD
Tiagabine—CYP3A4—Paclitaxel—breast cancer	0.0108	0.0262	CbGbCtD
Tiagabine—CYP3A4—Irinotecan—breast cancer	0.0106	0.0258	CbGbCtD
Tiagabine—CYP3A4—Vinblastine—breast cancer	0.00945	0.023	CbGbCtD
Tiagabine—CYP3A4—Docetaxel—breast cancer	0.00779	0.0189	CbGbCtD
Tiagabine—CYP3A4—Doxorubicin—breast cancer	0.00581	0.0141	CbGbCtD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.00077	0.0115	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—GSTA1—breast cancer	0.000769	0.0115	CbGpPWpGaD
Tiagabine—CYP3A4—Irinotecan Pathway—SLCO1B1—breast cancer	0.000667	0.00993	CbGpPWpGaD
Tiagabine—SLC6A1—Monoamine Transport—IL1B—breast cancer	0.000664	0.00988	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000663	0.00987	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—SLC2A2—breast cancer	0.000633	0.00942	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000587	0.00874	CbGpPWpGaD
Tiagabine—CYP3A4—Drug Induction of Bile Acid Pathway—SLCO1B1—breast cancer	0.000571	0.0085	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—TGFB2—breast cancer	0.000553	0.00823	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000536	0.00799	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000536	0.00799	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—SQSTM1—breast cancer	0.000523	0.00778	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—SLC5A5—breast cancer	0.000507	0.00756	CbGpPWpGaD
Tiagabine—CYP3A4—Fatty Acid Omega Oxidation—ALDH1A1—breast cancer	0.000492	0.00733	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—NQO1—breast cancer	0.00049	0.0073	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—SLC2A1—breast cancer	0.00049	0.0073	CbGpPWpGaD
Tiagabine—CYP3A4—Irinotecan Pathway—ABCC1—breast cancer	0.000488	0.00727	CbGpPWpGaD
Tiagabine—SLC6A1—Monoamine Transport—TNF—breast cancer	0.000481	0.00717	CbGpPWpGaD
Tiagabine—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—breast cancer	0.000463	0.00689	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—HSP90AA1—breast cancer	0.000461	0.00686	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—ACHE—breast cancer	0.000458	0.00683	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—EGR1—breast cancer	0.000455	0.00678	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000445	0.00662	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—COX11—breast cancer	0.000445	0.00662	CbGpPWpGaD
Tiagabine—CYP3A4—Tryptophan metabolism—ALDH3A2—breast cancer	0.000433	0.00645	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—TGFBR2—breast cancer	0.000409	0.00609	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—GSTP1—breast cancer	0.000409	0.00609	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000407	0.00605	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—HMOX1—breast cancer	0.000403	0.006	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—BCHE—breast cancer	0.000399	0.00595	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000399	0.00594	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000391	0.00583	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000391	0.00583	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—GSTM1—breast cancer	0.000376	0.00559	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—HGF—breast cancer	0.000376	0.00559	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—NRG1—breast cancer	0.000369	0.00549	CbGpPWpGaD
Tiagabine—CYP3A4—Liver X Receptor Pathway—FASN—breast cancer	0.000368	0.00549	CbGpPWpGaD
Tiagabine—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—breast cancer	0.000365	0.00544	CbGpPWpGaD
Tiagabine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—breast cancer	0.000357	0.00531	CbGpPWpGaD
Tiagabine—CYP3A4—Estrogen metabolism—SULT1A1—breast cancer	0.000351	0.00523	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—ACHE—breast cancer	0.000351	0.00523	CbGpPWpGaD
Tiagabine—CYP3A4—Estrogen metabolism—GSTA1—breast cancer	0.000343	0.00511	CbGpPWpGaD
Tiagabine—CYP3A4—Irinotecan Pathway—ABCG2—breast cancer	0.000338	0.00504	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000337	0.00502	CbGpPWpGaD
Tiagabine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—breast cancer	0.00033	0.00492	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.00032	0.00476	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—COMT—breast cancer	0.000319	0.00475	CbGpPWpGaD
Tiagabine—CYP3A4—Tamoxifen metabolism—SULT1A1—breast cancer	0.000311	0.00463	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000309	0.0046	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000308	0.00459	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—BCHE—breast cancer	0.000306	0.00456	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000286	0.00427	CbGpPWpGaD
Tiagabine—CYP3A4—Irinotecan Pathway—BCHE—breast cancer	0.00028	0.00417	CbGpPWpGaD
Tiagabine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—breast cancer	0.000277	0.00412	CbGpPWpGaD
Tiagabine—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—breast cancer	0.000266	0.00396	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—COMT—breast cancer	0.000245	0.00364	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000244	0.00363	CbGpPWpGaD
Tiagabine—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—breast cancer	0.000225	0.00334	CbGpPWpGaD
Tiagabine—CYP3A4—Xenobiotics—CYP2D6—breast cancer	0.000222	0.00331	CbGpPWpGaD
Tiagabine—CYP3A4—Constitutive Androstane Receptor Pathway—SULT1A1—breast cancer	0.000222	0.0033	CbGpPWpGaD
Tiagabine—CYP3A4—Estrogen metabolism—NQO1—breast cancer	0.000219	0.00326	CbGpPWpGaD
Tiagabine—CYP3A4—Tamoxifen metabolism—CYP2D6—breast cancer	0.000214	0.00318	CbGpPWpGaD
Tiagabine—CYP3A4—Tryptophan metabolism—ALDH1A1—breast cancer	0.000211	0.00315	CbGpPWpGaD
Tiagabine—CYP3A4—Estrogen metabolism—CYP1B1—breast cancer	0.00021	0.00312	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—BRAF—breast cancer	0.000204	0.00304	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000203	0.00302	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000199	0.00296	CbGpPWpGaD
Tiagabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—breast cancer	0.000187	0.00278	CbGpPWpGaD
Tiagabine—CYP3A4—Tamoxifen metabolism—CYP1B1—breast cancer	0.000185	0.00276	CbGpPWpGaD
Tiagabine—CYP3A4—Estrogen metabolism—COMT—breast cancer	0.000183	0.00273	CbGpPWpGaD
Tiagabine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—breast cancer	0.000181	0.00269	CbGpPWpGaD
Tiagabine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—breast cancer	0.00018	0.00269	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—TFRC—breast cancer	0.000177	0.00264	CbGpPWpGaD
Tiagabine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—breast cancer	0.000175	0.0026	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—MDM2—breast cancer	0.000171	0.00254	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—NCOA2—breast cancer	0.00017	0.00254	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—RAF1—breast cancer	0.00017	0.00253	CbGpPWpGaD
Tiagabine—CYP3A4—Estrogen metabolism—GSTM1—breast cancer	0.000168	0.0025	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000163	0.00242	CbGpPWpGaD
Tiagabine—CYP3A4—Estrogen metabolism—CYP1A1—breast cancer	0.000159	0.00237	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.000157	0.00234	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—BRAF—breast cancer	0.000156	0.00233	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—TGFB1—breast cancer	0.000153	0.00228	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—ALB—breast cancer	0.000153	0.00227	CbGpPWpGaD
Tiagabine—CYP3A4—Irinotecan Pathway—APC—breast cancer	0.000152	0.00227	CbGpPWpGaD
Tiagabine—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA2—breast cancer	0.00015	0.00223	CbGpPWpGaD
Tiagabine—CYP3A4—Xenobiotics—CYP1A1—breast cancer	0.000146	0.00218	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—NCOA1—breast cancer	0.000144	0.00214	CbGpPWpGaD
Tiagabine—CYP3A4—Tamoxifen metabolism—CYP1A1—breast cancer	0.00014	0.00209	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—PLG—breast cancer	0.00014	0.00208	CbGpPWpGaD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—ALDH1A1—breast cancer	0.000139	0.00206	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—MDM2—breast cancer	0.000131	0.00195	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—RAF1—breast cancer	0.00013	0.00194	CbGpPWpGaD
Tiagabine—CYP3A4—Constitutive Androstane Receptor Pathway—HSP90AA1—breast cancer	0.00013	0.00193	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—HMOX1—breast cancer	0.000129	0.00192	CbGpPWpGaD
Tiagabine—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA1—breast cancer	0.000126	0.00188	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ABCB1—breast cancer	0.000124	0.00185	CbGpPWpGaD
Tiagabine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—breast cancer	0.000109	0.00162	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—CHST9—breast cancer	0.000106	0.00158	CbGpPWpGaD
Tiagabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—breast cancer	0.000104	0.00155	CbGpPWpGaD
Tiagabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—breast cancer	0.000104	0.00154	CbGpPWpGaD
Tiagabine—CYP3A4—Tryptophan metabolism—CYP1B1—breast cancer	9.9e-05	0.00147	CbGpPWpGaD
Tiagabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—breast cancer	9.51e-05	0.00142	CbGpPWpGaD
Tiagabine—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—breast cancer	9.38e-05	0.0014	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—HRAS—breast cancer	9.37e-05	0.0014	CbGpPWpGaD
Tiagabine—CYP3A4—Tryptophan metabolism—CYP19A1—breast cancer	9.31e-05	0.00139	CbGpPWpGaD
Tiagabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—breast cancer	9.23e-05	0.00137	CbGpPWpGaD
Tiagabine—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—breast cancer	9.11e-05	0.00136	CbGpPWpGaD
Tiagabine—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA2—breast cancer	9.06e-05	0.00135	CbGpPWpGaD
Tiagabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—breast cancer	8e-05	0.00119	CbGpPWpGaD
Tiagabine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—breast cancer	7.9e-05	0.00118	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ALB—breast cancer	7.75e-05	0.00115	CbGpPWpGaD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—breast cancer	7.71e-05	0.00115	CbGpPWpGaD
Tiagabine—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA1—breast cancer	7.63e-05	0.00114	CbGpPWpGaD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—breast cancer	7.63e-05	0.00114	CbGpPWpGaD
Tiagabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—breast cancer	7.52e-05	0.00112	CbGpPWpGaD
Tiagabine—CYP3A4—Tryptophan metabolism—CYP1A1—breast cancer	7.5e-05	0.00112	CbGpPWpGaD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—breast cancer	7.48e-05	0.00111	CbGpPWpGaD
Tiagabine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—breast cancer	7.43e-05	0.00111	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—ALDH1A1—breast cancer	7.36e-05	0.0011	CbGpPWpGaD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—NCOA2—breast cancer	7.34e-05	0.00109	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—HRAS—breast cancer	7.18e-05	0.00107	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—RAF1—breast cancer	7.01e-05	0.00104	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—GSTA3—breast cancer	6.56e-05	0.000977	CbGpPWpGaD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—breast cancer	6.49e-05	0.000966	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—GSTA3—breast cancer	6.47e-05	0.000964	CbGpPWpGaD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—breast cancer	6.19e-05	0.000922	CbGpPWpGaD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—breast cancer	6.1e-05	0.000908	CbGpPWpGaD
Tiagabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—breast cancer	6.07e-05	0.000903	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—GSTA4—breast cancer	6e-05	0.000894	CbGpPWpGaD
Tiagabine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—breast cancer	5.99e-05	0.000891	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—GSTA4—breast cancer	5.92e-05	0.000881	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—GSTA2—breast cancer	5.85e-05	0.000871	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—SULT1A1—breast cancer	5.78e-05	0.00086	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—GPX2—breast cancer	5.77e-05	0.000859	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—GPX4—breast cancer	5.7e-05	0.000848	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—SULT1A1—breast cancer	5.7e-05	0.000848	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—GSTA1—breast cancer	5.64e-05	0.00084	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—NAT2—breast cancer	5.58e-05	0.000831	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—NAT2—breast cancer	5.5e-05	0.000819	CbGpPWpGaD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—breast cancer	4.92e-05	0.000732	CbGpPWpGaD
Tiagabine—CYP3A4—Tryptophan metabolism—MDM2—breast cancer	4.63e-05	0.000689	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—MTR—breast cancer	4.55e-05	0.000677	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—HPGDS—breast cancer	4.46e-05	0.000664	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—GSTT1—breast cancer	4.33e-05	0.000644	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—CYP17A1—breast cancer	4.09e-05	0.00061	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—PTGS1—breast cancer	4.05e-05	0.000604	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—CYP17A1—breast cancer	4.04e-05	0.000601	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—CYP2D6—breast cancer	3.97e-05	0.000592	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—CYP2D6—breast cancer	3.92e-05	0.000584	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—NCOA2—breast cancer	3.9e-05	0.000581	CbGpPWpGaD
Tiagabine—Dizziness—Fluorouracil—breast cancer	3.77e-05	0.000152	CcSEcCtD
Tiagabine—Visual impairment—Epirubicin—breast cancer	3.76e-05	0.000152	CcSEcCtD
Tiagabine—Rash—Mitoxantrone—breast cancer	3.75e-05	0.000151	CcSEcCtD
Tiagabine—Rash—Irinotecan—breast cancer	3.75e-05	0.000151	CcSEcCtD
Tiagabine—Dermatitis—Mitoxantrone—breast cancer	3.75e-05	0.000151	CcSEcCtD
Tiagabine—Dermatitis—Irinotecan—breast cancer	3.75e-05	0.000151	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Docetaxel—breast cancer	3.74e-05	0.000151	CcSEcCtD
Tiagabine—Chills—Methotrexate—breast cancer	3.74e-05	0.000151	CcSEcCtD
Tiagabine—Headache—Mitoxantrone—breast cancer	3.73e-05	0.00015	CcSEcCtD
Tiagabine—Headache—Irinotecan—breast cancer	3.73e-05	0.00015	CcSEcCtD
Tiagabine—Hypotension—Capecitabine—breast cancer	3.72e-05	0.00015	CcSEcCtD
Tiagabine—Insomnia—Docetaxel—breast cancer	3.72e-05	0.00015	CcSEcCtD
Tiagabine—Paraesthesia—Docetaxel—breast cancer	3.69e-05	0.000149	CcSEcCtD
Tiagabine—Alopecia—Methotrexate—breast cancer	3.68e-05	0.000149	CcSEcCtD
Tiagabine—Vomiting—Gemcitabine—breast cancer	3.68e-05	0.000148	CcSEcCtD
Tiagabine—Dyspnoea—Docetaxel—breast cancer	3.66e-05	0.000148	CcSEcCtD
Tiagabine—Somnolence—Docetaxel—breast cancer	3.65e-05	0.000147	CcSEcCtD
Tiagabine—Rash—Gemcitabine—breast cancer	3.65e-05	0.000147	CcSEcCtD
Tiagabine—Dermatitis—Gemcitabine—breast cancer	3.65e-05	0.000147	CcSEcCtD
Tiagabine—Tinnitus—Epirubicin—breast cancer	3.64e-05	0.000147	CcSEcCtD
Tiagabine—Haemoglobin—Doxorubicin—breast cancer	3.63e-05	0.000146	CcSEcCtD
Tiagabine—Headache—Gemcitabine—breast cancer	3.63e-05	0.000146	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Capecitabine—breast cancer	3.63e-05	0.000146	CcSEcCtD
Tiagabine—Vomiting—Fluorouracil—breast cancer	3.62e-05	0.000146	CcSEcCtD
Tiagabine—Rhinitis—Doxorubicin—breast cancer	3.62e-05	0.000146	CcSEcCtD
Tiagabine—Dyspepsia—Docetaxel—breast cancer	3.62e-05	0.000146	CcSEcCtD
Tiagabine—Haemorrhage—Doxorubicin—breast cancer	3.61e-05	0.000146	CcSEcCtD
Tiagabine—Insomnia—Capecitabine—breast cancer	3.6e-05	0.000145	CcSEcCtD
Tiagabine—Hypoaesthesia—Doxorubicin—breast cancer	3.59e-05	0.000145	CcSEcCtD
Tiagabine—Rash—Fluorouracil—breast cancer	3.59e-05	0.000145	CcSEcCtD
Tiagabine—Dermatitis—Fluorouracil—breast cancer	3.59e-05	0.000145	CcSEcCtD
Tiagabine—Pharyngitis—Doxorubicin—breast cancer	3.58e-05	0.000144	CcSEcCtD
Tiagabine—Paraesthesia—Capecitabine—breast cancer	3.57e-05	0.000144	CcSEcCtD
Tiagabine—Decreased appetite—Docetaxel—breast cancer	3.57e-05	0.000144	CcSEcCtD
Tiagabine—Hypersensitivity—Paclitaxel—breast cancer	3.57e-05	0.000144	CcSEcCtD
Tiagabine—Headache—Fluorouracil—breast cancer	3.57e-05	0.000144	CcSEcCtD
Tiagabine—Oedema peripheral—Doxorubicin—breast cancer	3.56e-05	0.000143	CcSEcCtD
Tiagabine—Dysgeusia—Methotrexate—breast cancer	3.55e-05	0.000143	CcSEcCtD
Tiagabine—Dyspnoea—Capecitabine—breast cancer	3.55e-05	0.000143	CcSEcCtD
Tiagabine—Fatigue—Docetaxel—breast cancer	3.54e-05	0.000143	CcSEcCtD
Tiagabine—Nausea—Irinotecan—breast cancer	3.53e-05	0.000142	CcSEcCtD
Tiagabine—Nausea—Mitoxantrone—breast cancer	3.53e-05	0.000142	CcSEcCtD
Tiagabine—Pain—Docetaxel—breast cancer	3.51e-05	0.000142	CcSEcCtD
Tiagabine—Constipation—Docetaxel—breast cancer	3.51e-05	0.000142	CcSEcCtD
Tiagabine—Back pain—Methotrexate—breast cancer	3.51e-05	0.000142	CcSEcCtD
Tiagabine—Dyspepsia—Capecitabine—breast cancer	3.5e-05	0.000141	CcSEcCtD
Tiagabine—Chills—Epirubicin—breast cancer	3.5e-05	0.000141	CcSEcCtD
Tiagabine—Visual impairment—Doxorubicin—breast cancer	3.48e-05	0.00014	CcSEcCtD
Tiagabine—Asthenia—Paclitaxel—breast cancer	3.48e-05	0.00014	CcSEcCtD
Tiagabine—Decreased appetite—Capecitabine—breast cancer	3.46e-05	0.000139	CcSEcCtD
Tiagabine—Alopecia—Epirubicin—breast cancer	3.45e-05	0.000139	CcSEcCtD
Tiagabine—CYP3A4—Biological oxidations—CYP1B1—breast cancer	3.45e-05	0.000513	CbGpPWpGaD
Tiagabine—Nausea—Gemcitabine—breast cancer	3.44e-05	0.000139	CcSEcCtD
Tiagabine—Fatigue—Capecitabine—breast cancer	3.43e-05	0.000138	CcSEcCtD
Tiagabine—Pruritus—Paclitaxel—breast cancer	3.43e-05	0.000138	CcSEcCtD
Tiagabine—Pain—Capecitabine—breast cancer	3.4e-05	0.000137	CcSEcCtD
Tiagabine—Constipation—Capecitabine—breast cancer	3.4e-05	0.000137	CcSEcCtD
Tiagabine—CYP3A4—Metapathway biotransformation—CYP1B1—breast cancer	3.4e-05	0.000506	CbGpPWpGaD
Tiagabine—Feeling abnormal—Docetaxel—breast cancer	3.39e-05	0.000137	CcSEcCtD
Tiagabine—Nausea—Fluorouracil—breast cancer	3.38e-05	0.000136	CcSEcCtD
Tiagabine—Ill-defined disorder—Methotrexate—breast cancer	3.37e-05	0.000136	CcSEcCtD
Tiagabine—Tinnitus—Doxorubicin—breast cancer	3.37e-05	0.000136	CcSEcCtD
Tiagabine—Gastrointestinal pain—Docetaxel—breast cancer	3.36e-05	0.000136	CcSEcCtD
Tiagabine—Anaemia—Methotrexate—breast cancer	3.36e-05	0.000135	CcSEcCtD
Tiagabine—Flatulence—Epirubicin—breast cancer	3.35e-05	0.000135	CcSEcCtD
Tiagabine—Tension—Epirubicin—breast cancer	3.33e-05	0.000134	CcSEcCtD
Tiagabine—Dysgeusia—Epirubicin—breast cancer	3.33e-05	0.000134	CcSEcCtD
Tiagabine—Diarrhoea—Paclitaxel—breast cancer	3.32e-05	0.000134	CcSEcCtD
Tiagabine—Nervousness—Epirubicin—breast cancer	3.3e-05	0.000133	CcSEcCtD
Tiagabine—CYP3A4—Biological oxidations—NCOA1—breast cancer	3.29e-05	0.00049	CbGpPWpGaD
Tiagabine—Back pain—Epirubicin—breast cancer	3.29e-05	0.000132	CcSEcCtD
Tiagabine—Feeling abnormal—Capecitabine—breast cancer	3.28e-05	0.000132	CcSEcCtD
Tiagabine—Malaise—Methotrexate—breast cancer	3.27e-05	0.000132	CcSEcCtD
Tiagabine—Muscle spasms—Epirubicin—breast cancer	3.27e-05	0.000132	CcSEcCtD
Tiagabine—Vertigo—Methotrexate—breast cancer	3.26e-05	0.000131	CcSEcCtD
Tiagabine—Gastrointestinal pain—Capecitabine—breast cancer	3.25e-05	0.000131	CcSEcCtD
Tiagabine—Abdominal pain—Docetaxel—breast cancer	3.25e-05	0.000131	CcSEcCtD
Tiagabine—Body temperature increased—Docetaxel—breast cancer	3.25e-05	0.000131	CcSEcCtD
Tiagabine—Leukopenia—Methotrexate—breast cancer	3.25e-05	0.000131	CcSEcCtD
Tiagabine—CYP3A4—Biological oxidations—CYP19A1—breast cancer	3.24e-05	0.000483	CbGpPWpGaD
Tiagabine—Chills—Doxorubicin—breast cancer	3.24e-05	0.000131	CcSEcCtD
Tiagabine—Dizziness—Paclitaxel—breast cancer	3.21e-05	0.000129	CcSEcCtD
Tiagabine—CYP3A4—Metapathway biotransformation—CYP19A1—breast cancer	3.2e-05	0.000476	CbGpPWpGaD
Tiagabine—Alopecia—Doxorubicin—breast cancer	3.19e-05	0.000129	CcSEcCtD
Tiagabine—Cough—Methotrexate—breast cancer	3.17e-05	0.000128	CcSEcCtD
Tiagabine—Urticaria—Capecitabine—breast cancer	3.16e-05	0.000127	CcSEcCtD
Tiagabine—Ill-defined disorder—Epirubicin—breast cancer	3.15e-05	0.000127	CcSEcCtD
Tiagabine—Body temperature increased—Capecitabine—breast cancer	3.15e-05	0.000127	CcSEcCtD
Tiagabine—Abdominal pain—Capecitabine—breast cancer	3.15e-05	0.000127	CcSEcCtD
Tiagabine—Anaemia—Epirubicin—breast cancer	3.14e-05	0.000127	CcSEcCtD
Tiagabine—Agitation—Epirubicin—breast cancer	3.12e-05	0.000126	CcSEcCtD
Tiagabine—Flatulence—Doxorubicin—breast cancer	3.1e-05	0.000125	CcSEcCtD
Tiagabine—Chest pain—Methotrexate—breast cancer	3.09e-05	0.000125	CcSEcCtD
Tiagabine—Arthralgia—Methotrexate—breast cancer	3.09e-05	0.000125	CcSEcCtD
Tiagabine—Myalgia—Methotrexate—breast cancer	3.09e-05	0.000125	CcSEcCtD
Tiagabine—Tension—Doxorubicin—breast cancer	3.08e-05	0.000124	CcSEcCtD
Tiagabine—Vomiting—Paclitaxel—breast cancer	3.08e-05	0.000124	CcSEcCtD
Tiagabine—Dysgeusia—Doxorubicin—breast cancer	3.08e-05	0.000124	CcSEcCtD
Tiagabine—Malaise—Epirubicin—breast cancer	3.06e-05	0.000124	CcSEcCtD
Tiagabine—Rash—Paclitaxel—breast cancer	3.06e-05	0.000123	CcSEcCtD
Tiagabine—Dermatitis—Paclitaxel—breast cancer	3.05e-05	0.000123	CcSEcCtD
Tiagabine—Discomfort—Methotrexate—breast cancer	3.05e-05	0.000123	CcSEcCtD
Tiagabine—Nervousness—Doxorubicin—breast cancer	3.05e-05	0.000123	CcSEcCtD
Tiagabine—Vertigo—Epirubicin—breast cancer	3.05e-05	0.000123	CcSEcCtD
Tiagabine—Syncope—Epirubicin—breast cancer	3.05e-05	0.000123	CcSEcCtD
Tiagabine—Leukopenia—Epirubicin—breast cancer	3.04e-05	0.000123	CcSEcCtD
Tiagabine—Back pain—Doxorubicin—breast cancer	3.04e-05	0.000123	CcSEcCtD
Tiagabine—Headache—Paclitaxel—breast cancer	3.04e-05	0.000122	CcSEcCtD
Tiagabine—Hypersensitivity—Docetaxel—breast cancer	3.03e-05	0.000122	CcSEcCtD
Tiagabine—Muscle spasms—Doxorubicin—breast cancer	3.02e-05	0.000122	CcSEcCtD
Tiagabine—CYP3A4—Biological oxidations—COMT—breast cancer	3.01e-05	0.000449	CbGpPWpGaD
Tiagabine—Palpitations—Epirubicin—breast cancer	3e-05	0.000121	CcSEcCtD
Tiagabine—CYP3A4—Biological oxidations—GSTP1—breast cancer	3e-05	0.000446	CbGpPWpGaD
Tiagabine—Confusional state—Methotrexate—breast cancer	2.99e-05	0.00012	CcSEcCtD
Tiagabine—Loss of consciousness—Epirubicin—breast cancer	2.99e-05	0.00012	CcSEcCtD
Tiagabine—CYP3A4—Metapathway biotransformation—COMT—breast cancer	2.97e-05	0.000442	CbGpPWpGaD
Tiagabine—Cough—Epirubicin—breast cancer	2.96e-05	0.00012	CcSEcCtD
Tiagabine—CYP3A4—Metapathway biotransformation—GSTP1—breast cancer	2.96e-05	0.00044	CbGpPWpGaD
Tiagabine—Asthenia—Docetaxel—breast cancer	2.95e-05	0.000119	CcSEcCtD
Tiagabine—Infection—Methotrexate—breast cancer	2.94e-05	0.000119	CcSEcCtD
Tiagabine—Hypertension—Epirubicin—breast cancer	2.93e-05	0.000118	CcSEcCtD
Tiagabine—Hypersensitivity—Capecitabine—breast cancer	2.93e-05	0.000118	CcSEcCtD
Tiagabine—Ill-defined disorder—Doxorubicin—breast cancer	2.92e-05	0.000118	CcSEcCtD
Tiagabine—Pruritus—Docetaxel—breast cancer	2.91e-05	0.000117	CcSEcCtD
Tiagabine—Anaemia—Doxorubicin—breast cancer	2.91e-05	0.000117	CcSEcCtD
Tiagabine—Thrombocytopenia—Methotrexate—breast cancer	2.9e-05	0.000117	CcSEcCtD
Tiagabine—Myalgia—Epirubicin—breast cancer	2.89e-05	0.000117	CcSEcCtD
Tiagabine—Chest pain—Epirubicin—breast cancer	2.89e-05	0.000117	CcSEcCtD
Tiagabine—Arthralgia—Epirubicin—breast cancer	2.89e-05	0.000117	CcSEcCtD
Tiagabine—Agitation—Doxorubicin—breast cancer	2.89e-05	0.000116	CcSEcCtD
Tiagabine—Anxiety—Epirubicin—breast cancer	2.88e-05	0.000116	CcSEcCtD
Tiagabine—Nausea—Paclitaxel—breast cancer	2.88e-05	0.000116	CcSEcCtD
Tiagabine—Hyperhidrosis—Methotrexate—breast cancer	2.86e-05	0.000115	CcSEcCtD
Tiagabine—Discomfort—Epirubicin—breast cancer	2.86e-05	0.000115	CcSEcCtD
Tiagabine—Asthenia—Capecitabine—breast cancer	2.86e-05	0.000115	CcSEcCtD
Tiagabine—Malaise—Doxorubicin—breast cancer	2.83e-05	0.000114	CcSEcCtD
Tiagabine—Dry mouth—Epirubicin—breast cancer	2.83e-05	0.000114	CcSEcCtD
Tiagabine—Vertigo—Doxorubicin—breast cancer	2.82e-05	0.000114	CcSEcCtD
Tiagabine—Anorexia—Methotrexate—breast cancer	2.82e-05	0.000114	CcSEcCtD
Tiagabine—Syncope—Doxorubicin—breast cancer	2.82e-05	0.000114	CcSEcCtD
Tiagabine—Pruritus—Capecitabine—breast cancer	2.82e-05	0.000114	CcSEcCtD
Tiagabine—Leukopenia—Doxorubicin—breast cancer	2.81e-05	0.000113	CcSEcCtD
Tiagabine—Diarrhoea—Docetaxel—breast cancer	2.81e-05	0.000113	CcSEcCtD
Tiagabine—Confusional state—Epirubicin—breast cancer	2.8e-05	0.000113	CcSEcCtD
Tiagabine—Palpitations—Doxorubicin—breast cancer	2.78e-05	0.000112	CcSEcCtD
Tiagabine—Oedema—Epirubicin—breast cancer	2.77e-05	0.000112	CcSEcCtD
Tiagabine—Hypotension—Methotrexate—breast cancer	2.77e-05	0.000112	CcSEcCtD
Tiagabine—Loss of consciousness—Doxorubicin—breast cancer	2.76e-05	0.000111	CcSEcCtD
Tiagabine—CYP3A4—Biological oxidations—GSTM1—breast cancer	2.76e-05	0.00041	CbGpPWpGaD
Tiagabine—Infection—Epirubicin—breast cancer	2.75e-05	0.000111	CcSEcCtD
Tiagabine—Cough—Doxorubicin—breast cancer	2.74e-05	0.000111	CcSEcCtD
Tiagabine—Shock—Epirubicin—breast cancer	2.73e-05	0.00011	CcSEcCtD
Tiagabine—Diarrhoea—Capecitabine—breast cancer	2.72e-05	0.00011	CcSEcCtD
Tiagabine—Dizziness—Docetaxel—breast cancer	2.72e-05	0.00011	CcSEcCtD
Tiagabine—CYP3A4—Metapathway biotransformation—GSTM1—breast cancer	2.72e-05	0.000405	CbGpPWpGaD
Tiagabine—Thrombocytopenia—Epirubicin—breast cancer	2.71e-05	0.000109	CcSEcCtD
Tiagabine—Hypertension—Doxorubicin—breast cancer	2.71e-05	0.000109	CcSEcCtD
Tiagabine—Tachycardia—Epirubicin—breast cancer	2.71e-05	0.000109	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Methotrexate—breast cancer	2.7e-05	0.000109	CcSEcCtD
Tiagabine—Hyperhidrosis—Epirubicin—breast cancer	2.68e-05	0.000108	CcSEcCtD
Tiagabine—Insomnia—Methotrexate—breast cancer	2.68e-05	0.000108	CcSEcCtD
Tiagabine—Arthralgia—Doxorubicin—breast cancer	2.68e-05	0.000108	CcSEcCtD
Tiagabine—Chest pain—Doxorubicin—breast cancer	2.68e-05	0.000108	CcSEcCtD
Tiagabine—Myalgia—Doxorubicin—breast cancer	2.68e-05	0.000108	CcSEcCtD
Tiagabine—Anxiety—Doxorubicin—breast cancer	2.67e-05	0.000108	CcSEcCtD
Tiagabine—Paraesthesia—Methotrexate—breast cancer	2.66e-05	0.000107	CcSEcCtD
Tiagabine—Discomfort—Doxorubicin—breast cancer	2.64e-05	0.000107	CcSEcCtD
Tiagabine—Anorexia—Epirubicin—breast cancer	2.64e-05	0.000107	CcSEcCtD
Tiagabine—Dyspnoea—Methotrexate—breast cancer	2.64e-05	0.000106	CcSEcCtD
Tiagabine—Somnolence—Methotrexate—breast cancer	2.63e-05	0.000106	CcSEcCtD
Tiagabine—Dizziness—Capecitabine—breast cancer	2.63e-05	0.000106	CcSEcCtD
Tiagabine—Dry mouth—Doxorubicin—breast cancer	2.62e-05	0.000106	CcSEcCtD
Tiagabine—Vomiting—Docetaxel—breast cancer	2.61e-05	0.000105	CcSEcCtD
Tiagabine—CYP3A4—Biological oxidations—CYP1A1—breast cancer	2.61e-05	0.000389	CbGpPWpGaD
Tiagabine—Dyspepsia—Methotrexate—breast cancer	2.61e-05	0.000105	CcSEcCtD
Tiagabine—Rash—Docetaxel—breast cancer	2.59e-05	0.000104	CcSEcCtD
Tiagabine—Hypotension—Epirubicin—breast cancer	2.59e-05	0.000104	CcSEcCtD
Tiagabine—Dermatitis—Docetaxel—breast cancer	2.59e-05	0.000104	CcSEcCtD
Tiagabine—Confusional state—Doxorubicin—breast cancer	2.59e-05	0.000104	CcSEcCtD
Tiagabine—CYP3A4—Metapathway biotransformation—CYP1A1—breast cancer	2.58e-05	0.000384	CbGpPWpGaD
Tiagabine—Decreased appetite—Methotrexate—breast cancer	2.58e-05	0.000104	CcSEcCtD
Tiagabine—Headache—Docetaxel—breast cancer	2.58e-05	0.000104	CcSEcCtD
Tiagabine—Oedema—Doxorubicin—breast cancer	2.57e-05	0.000103	CcSEcCtD
Tiagabine—Fatigue—Methotrexate—breast cancer	2.55e-05	0.000103	CcSEcCtD
Tiagabine—Infection—Doxorubicin—breast cancer	2.55e-05	0.000103	CcSEcCtD
Tiagabine—Pain—Methotrexate—breast cancer	2.53e-05	0.000102	CcSEcCtD
Tiagabine—Vomiting—Capecitabine—breast cancer	2.53e-05	0.000102	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Epirubicin—breast cancer	2.53e-05	0.000102	CcSEcCtD
Tiagabine—Shock—Doxorubicin—breast cancer	2.52e-05	0.000102	CcSEcCtD
Tiagabine—Thrombocytopenia—Doxorubicin—breast cancer	2.51e-05	0.000101	CcSEcCtD
Tiagabine—Rash—Capecitabine—breast cancer	2.51e-05	0.000101	CcSEcCtD
Tiagabine—Insomnia—Epirubicin—breast cancer	2.51e-05	0.000101	CcSEcCtD
Tiagabine—Dermatitis—Capecitabine—breast cancer	2.51e-05	0.000101	CcSEcCtD
Tiagabine—Tachycardia—Doxorubicin—breast cancer	2.5e-05	0.000101	CcSEcCtD
Tiagabine—Headache—Capecitabine—breast cancer	2.49e-05	0.000101	CcSEcCtD
Tiagabine—Paraesthesia—Epirubicin—breast cancer	2.49e-05	0.0001	CcSEcCtD
Tiagabine—Hyperhidrosis—Doxorubicin—breast cancer	2.48e-05	0.0001	CcSEcCtD
Tiagabine—Dyspnoea—Epirubicin—breast cancer	2.47e-05	9.97e-05	CcSEcCtD
Tiagabine—Somnolence—Epirubicin—breast cancer	2.46e-05	9.94e-05	CcSEcCtD
Tiagabine—Anorexia—Doxorubicin—breast cancer	2.45e-05	9.86e-05	CcSEcCtD
Tiagabine—Nausea—Docetaxel—breast cancer	2.44e-05	9.84e-05	CcSEcCtD
Tiagabine—Feeling abnormal—Methotrexate—breast cancer	2.44e-05	9.84e-05	CcSEcCtD
Tiagabine—Dyspepsia—Epirubicin—breast cancer	2.44e-05	9.84e-05	CcSEcCtD
Tiagabine—Gastrointestinal pain—Methotrexate—breast cancer	2.42e-05	9.77e-05	CcSEcCtD
Tiagabine—Decreased appetite—Epirubicin—breast cancer	2.41e-05	9.72e-05	CcSEcCtD
Tiagabine—Hypotension—Doxorubicin—breast cancer	2.4e-05	9.66e-05	CcSEcCtD
Tiagabine—Fatigue—Epirubicin—breast cancer	2.39e-05	9.64e-05	CcSEcCtD
Tiagabine—Pain—Epirubicin—breast cancer	2.37e-05	9.56e-05	CcSEcCtD
Tiagabine—Constipation—Epirubicin—breast cancer	2.37e-05	9.56e-05	CcSEcCtD
Tiagabine—Nausea—Capecitabine—breast cancer	2.36e-05	9.53e-05	CcSEcCtD
Tiagabine—Urticaria—Methotrexate—breast cancer	2.35e-05	9.49e-05	CcSEcCtD
Tiagabine—Abdominal pain—Methotrexate—breast cancer	2.34e-05	9.44e-05	CcSEcCtD
Tiagabine—Body temperature increased—Methotrexate—breast cancer	2.34e-05	9.44e-05	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.34e-05	9.42e-05	CcSEcCtD
Tiagabine—Insomnia—Doxorubicin—breast cancer	2.32e-05	9.35e-05	CcSEcCtD
Tiagabine—Paraesthesia—Doxorubicin—breast cancer	2.3e-05	9.29e-05	CcSEcCtD
Tiagabine—Dyspnoea—Doxorubicin—breast cancer	2.29e-05	9.22e-05	CcSEcCtD
Tiagabine—Feeling abnormal—Epirubicin—breast cancer	2.28e-05	9.21e-05	CcSEcCtD
Tiagabine—Somnolence—Doxorubicin—breast cancer	2.28e-05	9.19e-05	CcSEcCtD
Tiagabine—Gastrointestinal pain—Epirubicin—breast cancer	2.27e-05	9.14e-05	CcSEcCtD
Tiagabine—Dyspepsia—Doxorubicin—breast cancer	2.26e-05	9.1e-05	CcSEcCtD
Tiagabine—Decreased appetite—Doxorubicin—breast cancer	2.23e-05	8.99e-05	CcSEcCtD
Tiagabine—Fatigue—Doxorubicin—breast cancer	2.21e-05	8.92e-05	CcSEcCtD
Tiagabine—Urticaria—Epirubicin—breast cancer	2.2e-05	8.88e-05	CcSEcCtD
Tiagabine—Pain—Doxorubicin—breast cancer	2.19e-05	8.84e-05	CcSEcCtD
Tiagabine—Constipation—Doxorubicin—breast cancer	2.19e-05	8.84e-05	CcSEcCtD
Tiagabine—Body temperature increased—Epirubicin—breast cancer	2.19e-05	8.84e-05	CcSEcCtD
Tiagabine—Abdominal pain—Epirubicin—breast cancer	2.19e-05	8.84e-05	CcSEcCtD
Tiagabine—Hypersensitivity—Methotrexate—breast cancer	2.18e-05	8.8e-05	CcSEcCtD
Tiagabine—Asthenia—Methotrexate—breast cancer	2.13e-05	8.57e-05	CcSEcCtD
Tiagabine—Feeling abnormal—Doxorubicin—breast cancer	2.11e-05	8.52e-05	CcSEcCtD
Tiagabine—CYP3A4—Metabolism—SYNJ2—breast cancer	2.1e-05	0.000313	CbGpPWpGaD
Tiagabine—Gastrointestinal pain—Doxorubicin—breast cancer	2.1e-05	8.46e-05	CcSEcCtD
Tiagabine—Pruritus—Methotrexate—breast cancer	2.1e-05	8.45e-05	CcSEcCtD
Tiagabine—Hypersensitivity—Epirubicin—breast cancer	2.04e-05	8.24e-05	CcSEcCtD
Tiagabine—Urticaria—Doxorubicin—breast cancer	2.04e-05	8.22e-05	CcSEcCtD
Tiagabine—Abdominal pain—Doxorubicin—breast cancer	2.03e-05	8.18e-05	CcSEcCtD
Tiagabine—Body temperature increased—Doxorubicin—breast cancer	2.03e-05	8.18e-05	CcSEcCtD
Tiagabine—Diarrhoea—Methotrexate—breast cancer	2.03e-05	8.17e-05	CcSEcCtD
Tiagabine—Asthenia—Epirubicin—breast cancer	1.99e-05	8.02e-05	CcSEcCtD
Tiagabine—Pruritus—Epirubicin—breast cancer	1.96e-05	7.91e-05	CcSEcCtD
Tiagabine—Dizziness—Methotrexate—breast cancer	1.96e-05	7.9e-05	CcSEcCtD
Tiagabine—CYP3A4—Metabolism—NDUFS3—breast cancer	1.95e-05	0.000291	CbGpPWpGaD
Tiagabine—Diarrhoea—Epirubicin—breast cancer	1.9e-05	7.65e-05	CcSEcCtD
Tiagabine—Hypersensitivity—Doxorubicin—breast cancer	1.89e-05	7.62e-05	CcSEcCtD
Tiagabine—Vomiting—Methotrexate—breast cancer	1.88e-05	7.59e-05	CcSEcCtD
Tiagabine—Rash—Methotrexate—breast cancer	1.87e-05	7.53e-05	CcSEcCtD
Tiagabine—Dermatitis—Methotrexate—breast cancer	1.87e-05	7.52e-05	CcSEcCtD
Tiagabine—Headache—Methotrexate—breast cancer	1.86e-05	7.48e-05	CcSEcCtD
Tiagabine—Asthenia—Doxorubicin—breast cancer	1.84e-05	7.42e-05	CcSEcCtD
Tiagabine—CYP3A4—Metabolism—CHST9—breast cancer	1.84e-05	0.000274	CbGpPWpGaD
Tiagabine—Dizziness—Epirubicin—breast cancer	1.83e-05	7.39e-05	CcSEcCtD
Tiagabine—Pruritus—Doxorubicin—breast cancer	1.81e-05	7.32e-05	CcSEcCtD
Tiagabine—Vomiting—Epirubicin—breast cancer	1.76e-05	7.11e-05	CcSEcCtD
Tiagabine—Nausea—Methotrexate—breast cancer	1.76e-05	7.09e-05	CcSEcCtD
Tiagabine—Diarrhoea—Doxorubicin—breast cancer	1.76e-05	7.08e-05	CcSEcCtD
Tiagabine—Rash—Epirubicin—breast cancer	1.75e-05	7.05e-05	CcSEcCtD
Tiagabine—Dermatitis—Epirubicin—breast cancer	1.75e-05	7.04e-05	CcSEcCtD
Tiagabine—CYP3A4—Metabolism—COX11—breast cancer	1.74e-05	0.000259	CbGpPWpGaD
Tiagabine—Headache—Epirubicin—breast cancer	1.74e-05	7e-05	CcSEcCtD
Tiagabine—Dizziness—Doxorubicin—breast cancer	1.7e-05	6.84e-05	CcSEcCtD
Tiagabine—Nausea—Epirubicin—breast cancer	1.65e-05	6.64e-05	CcSEcCtD
Tiagabine—Vomiting—Doxorubicin—breast cancer	1.63e-05	6.58e-05	CcSEcCtD
Tiagabine—Rash—Doxorubicin—breast cancer	1.62e-05	6.52e-05	CcSEcCtD
Tiagabine—Dermatitis—Doxorubicin—breast cancer	1.62e-05	6.52e-05	CcSEcCtD
Tiagabine—Headache—Doxorubicin—breast cancer	1.61e-05	6.48e-05	CcSEcCtD
Tiagabine—CYP3A4—Metabolism—CDA—breast cancer	1.59e-05	0.000237	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SHMT1—breast cancer	1.59e-05	0.000237	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SLCO1B1—breast cancer	1.53e-05	0.000228	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SLC2A5—breast cancer	1.53e-05	0.000228	CbGpPWpGaD
Tiagabine—Nausea—Doxorubicin—breast cancer	1.52e-05	6.14e-05	CcSEcCtD
Tiagabine—CYP3A4—Metabolism—APRT—breast cancer	1.48e-05	0.00022	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ESRRA—breast cancer	1.39e-05	0.000207	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ANGPTL4—breast cancer	1.39e-05	0.000207	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HADHB—breast cancer	1.32e-05	0.000197	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GPI—breast cancer	1.32e-05	0.000197	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ALDH1A1—breast cancer	1.26e-05	0.000187	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ALDH7A1—breast cancer	1.26e-05	0.000187	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PHGDH—breast cancer	1.21e-05	0.00018	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—NME1—breast cancer	1.21e-05	0.00018	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ADSL—breast cancer	1.21e-05	0.00018	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—UMPS—breast cancer	1.21e-05	0.00018	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—FHL2—breast cancer	1.21e-05	0.00018	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HPSE—breast cancer	1.18e-05	0.000176	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—BRIP1—breast cancer	1.18e-05	0.000176	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—LDHB—breast cancer	1.18e-05	0.000176	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GSTA3—breast cancer	1.12e-05	0.000167	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HMMR—breast cancer	1.12e-05	0.000167	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ABCC1—breast cancer	1.12e-05	0.000167	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PPARGC1B—breast cancer	1.09e-05	0.000162	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GSTA4—breast cancer	1.03e-05	0.000153	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CA9—breast cancer	1.03e-05	0.000153	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GSTA2—breast cancer	1e-05	0.000149	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GPX2—breast cancer	1e-05	0.000149	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GPX4—breast cancer	9.88e-06	0.000147	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SULT1A1—breast cancer	9.88e-06	0.000147	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—IDH1—breast cancer	9.65e-06	0.000144	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GSTA1—breast cancer	9.65e-06	0.000144	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—NAT2—breast cancer	9.54e-06	0.000142	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—DPYD—breast cancer	8.36e-06	0.000125	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—MED12—breast cancer	8.36e-06	0.000125	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ALDOA—breast cancer	8.23e-06	0.000123	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—NCOA3—breast cancer	7.99e-06	0.000119	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SLC2A2—breast cancer	7.94e-06	0.000118	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ABCG2—breast cancer	7.78e-06	0.000116	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CPT1A—breast cancer	7.78e-06	0.000116	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—MTR—breast cancer	7.78e-06	0.000116	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HPGDS—breast cancer	7.63e-06	0.000114	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HBA1—breast cancer	7.58e-06	0.000113	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GSTT1—breast cancer	7.4e-06	0.00011	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ACHE—breast cancer	7.4e-06	0.00011	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CYP17A1—breast cancer	7e-06	0.000104	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PTGS1—breast cancer	6.93e-06	0.000103	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ENO1—breast cancer	6.93e-06	0.000103	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CYP2D6—breast cancer	6.8e-06	0.000101	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—NCOA2—breast cancer	6.67e-06	9.94e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—FASN—breast cancer	6.47e-06	9.64e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—BCHE—breast cancer	6.44e-06	9.6e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SLC5A5—breast cancer	6.36e-06	9.48e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SLC2A1—breast cancer	6.15e-06	9.15e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—NQO1—breast cancer	6.15e-06	9.15e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CYP1B1—breast cancer	5.89e-06	8.78e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HSP90AA1—breast cancer	5.78e-06	8.61e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—NCOA1—breast cancer	5.62e-06	8.37e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—STK11—breast cancer	5.54e-06	8.25e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CYP19A1—breast cancer	5.54e-06	8.25e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—COMT—breast cancer	5.15e-06	7.67e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GSTP1—breast cancer	5.13e-06	7.64e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HMOX1—breast cancer	5.06e-06	7.53e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ITPR1—breast cancer	5.05e-06	7.51e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ABCB1—breast cancer	4.85e-06	7.23e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—TYMS—breast cancer	4.77e-06	7.1e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PLA2G4A—breast cancer	4.71e-06	7.02e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GSTM1—breast cancer	4.71e-06	7.02e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—NCOR1—breast cancer	4.71e-06	7.02e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GPX1—breast cancer	4.51e-06	6.72e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CYP1A1—breast cancer	4.47e-06	6.65e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ERCC2—breast cancer	4.43e-06	6.6e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—MTHFR—breast cancer	4.16e-06	6.2e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CAV1—breast cancer	3.84e-06	5.72e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PIK3CG—breast cancer	3.5e-06	5.21e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PIK3CD—breast cancer	3.08e-06	4.58e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ALB—breast cancer	3.04e-06	4.52e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—NOS3—breast cancer	2.9e-06	4.33e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PIK3CB—breast cancer	2.68e-06	3.99e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PTGS2—breast cancer	2.66e-06	3.96e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PTEN—breast cancer	2.32e-06	3.45e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PIK3CA—breast cancer	1.63e-06	2.43e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—AKT1—breast cancer	1.33e-06	1.99e-05	CbGpPWpGaD
